The Middle East and North Africa laparoscopy devices market was valued at $752.0 million in 2021 and is anticipated to reach $1,731.4 million by 2031, witnessing a CAGR of 7.71% during the forecast period 2022-2031.

The market is driven by factors such as the rising preference for minimally invasive surgeries, increase in the prevalence of chronic diseases in the geriatric population, rising technological advancement, and increase in medical tourism in some countries.

Market Lifecycle Stage

The laparoscopy devices market is still in the development phase. Increased research and development activities are underway to develop more products. The market is driven by factors such as the rising preference for minimally invasive surgeries and increase in the prevalence of chronic diseases in the geriatric population, among others.

The rising preference for surgeries over open surgeries is leading to the increased demand for laparoscopy devices such as laparoscopes and energy devices, and the integration of industry with robotics is a major opportunity in the Middle East and North Africa laparoscopy devices market.

Impact of COVID-19

The COVID-19 pandemic led to the deferral of surgical procedures. The impact of COVID-19 on laparoscopy devices is ambiguous, as surgeries were limited during the pandemic. Before the COVID-19 pandemic, laparoscopic surgeries were majorly undertaken in hospitals and clinical facilities. Owing to factors such as travel restrictions and the risk of transmission of the virus, there was a decrease in laparoscopic surgeries.

As the recovery phase of the COVID-19 pandemic begins, laparoscopy device procedures are expected to normalize.

In addition to this, the COVID-19 pandemic also helped in the adoption of disposable laparoscopy devices. Single-use laparoscopy devices eliminate the risk of cross-contamination, which turned out to be a favorable condition for their adoption during the COVID-19 pandemic.

Market Segmentation:

Segmentation 1: by Product

• Conventional Laparoscopy Devices
o Laparoscopes
o Hand Instruments
o Access Devices
o Energy Devices
o Closure Devices
o Insufflators
o Others

• Robotic-Assisted Laparoscopy Devices
o Systems
o Instruments and Accessories
o Services

The Middle East and North Africa laparoscopy devices market (by product) is expected to be dominated by the conventional laparoscopy devices segment.

Segmentation 2: by Application

• General Surgery
• Gynecological Surgery
• Urological Surgery
• Bariatric Surgery
• Other Surgeries

General surgery is expected to be the major application in the Middle East and North Africa laparoscopy devices market.

Segmentation 3: by Country

• Turkey
• U.A.E
• K.S.A
• Israel
• Rest-of-Middle East and North Africa

The Middle East and North Africa laparoscopy devices market (by country) is expected to be dominated by Turkey.

Segmentation 4: by End User

• Hospitals
• Ambulatory Surgical Centres
• Others

The Middle East and North Africa laparoscopy devices market (by end user) is dominated by the hospital segment.

Recent Developments in Middle East and North Africa Laparoscopy Devices Market

• In January 2022, Seger Surgical Solutions Ltd announced that it had launched the next-generation laparoscopic stapler for intracorporeal anastomosis in the market.

• In September 2021, Olympus Corporation strengthened its surgical portfolio with the launch of POWERSEAL advanced bipolar surgical energy devices.

• In December 2021, Intuitive Surgical, Inc. received FDA clearance for an 8 mm SureForm 30 curved-tip stapler for use in general, thoracic, gynecologic, urologic, and pediatric surgery.

• In January 2020, KARL STORZ SE & Co KG introduced a new 3D surgical imaging system and modular camera platform at Arab Health 2020.

• In March 2019, Stryker Corporation acquired an Israel-based company named Orthospace Ltd. to expand its product portfolio.

• In June 2018, Stryker Corporation signed a definitive agreement to acquire SafeAir AG, a Swiss medical device company dedicated to the design, development, and manufacture of innovative surgical smoke evacuation solutions, for the expansion of the surgical business.

Demand – Drivers and Limitations

Following are the drivers for the Middle East and North Africa laparoscopy devices market:

• Rising Preference for Minimally Invasive Surgeries
• Increase in Prevalence of Chronic Diseases in Geriatric Population
• Rising Technological Advancements
• Increase in Medical Tourism in Countries

The market is expected to face some limitations too, due to the following challenges:

• High Cost of Robotic-Assisted Minimally Invasive Surgeries and Shortage of Skilled Professionals
• Lack of Reimbursement Policies

How can this report add value to an organization?

Type: The type segment helps the reader understand the different types of laparoscopy products available in the market. Moreover, the study provides the reader with a detailed understanding of products that fall under the two main segments, i.e., conventional laparoscopy devices and robotic assisted laparoscopy devices.

Growth/Marketing Strategy: The Middle East and North Africa laparoscopy devices market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been regulatory and legal activities, partnerships, alliances, and business expansions to strengthen their position in the market.

For instance, in March 2019, Stryker Corporation acquired an Israel-based company, named Orthospace Ltd., and in September 2021, Olympus Corporation strengthened its surgical portfolio with the launch of POWERSEAL advanced bipolar surgical energy devices.

Competitive Strategy: Key players in the global Middle East and North Africa laparoscopy devices market analyzed and profiled in the study involve established and emerging players that offer different products for laparoscopy devices.

Moreover, a detailed competitive benchmarking of the players operating in the global Middle East and North Africa laparoscopy devices market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the players in this market are:

• Applied Medical Resources Corporation
• Arthrex, Inc.
• Asensus Surgical, Inc.
• Barco N.V.
• B. Braun SE
• Boston Scientific Corporation
• CONMED Corporation
• Human Xtensions Ltd.
• Intuitive Surgical, Inc.
• Johnson & Johnson
• KARL STORZ SE & Co. KG
• Medtronic plc
• Olympus Corporation
• Peters Surgical
• Seger Surgical Solutions Ltd
• Stryker Corporation
• Virtual Ports

The post Middle East and North Africa Laparoscopy Devices Market – A Regional Analysis: Focus on Application, Products, End User, and Country – Analysis and Forecast, 2022-2031 first appeared on CRI Report.

The Canada laparoscopy devices market was valued at $392.1 million in 2021 and is anticipated to reach $865.6 million by 2031, witnessing a CAGR of 7.31% during the forecast period 2022-2031. The market is driven by factors such as the rising preference for minimally invasive surgeries, growing geriatric population, rising bariatric population, and rising approval for robotic surgical systems.

Market Lifecycle Stage

The Canada laparoscopy devices market is in the developed phase. The rising preference for laparoscopic surgeries over open surgeries is leading to increased demand for laparoscopy devices such as laparoscopes, energy devices, access and closure devices, and the integration of industry with robotics and AI are some of the major opportunities in the Canada laparoscopy devices market. Furthermore, some of the current key trends in the market are the shift from conventional surgeries to robot-assisted surgery, development and adoption of disposable laparoscopy devices, rising demand for minimally invasive procedures, and increasing number of product launches among market players.

Impact of COVID-19

The COVID-19 pandemic has impacted practically all sectors and social functions worldwide, including the Canada laparoscopy devices market. COVID-19 led to a decline in the Canada laparoscopy devices market, as elective and surgical procedures were stopped during the lockdown.

Overall, the supply side was negatively impacted, especially during the peak of the COVID-19 pandemic. The significantly high number of laparoscopic procedures resumed after the restrictions were lifted, which offset the negative impact and led to the growth of the market in 2021.

In addition to this, the COVID-19 pandemic also helped in the adoption of disposable laparoscopy devices. Single-use laparoscopy devices eliminate the risk of cross-contamination, which turned out to be a favorable condition for their adoption during the COVID-19 pandemic.

Market Segmentation:

Segmentation 1: by Product

• Conventional Laparoscopy Devices
o Laparoscopes
o Energy Devices
o Hand Instruments
o Access Devices
o Closure Devices
o Insufflators
o Others
• Robotic-Assisted Laparoscopy Devices
o Robotic Systems
o Instruments and Accessories
o Services

The conventional laparoscopy devices segment holds the larger share in the Canada laparoscopy devices market at $350.6 million compared to the robotic-assisted laparoscopy devices segment which is valued at $41.5 million in the year 2021.

Segmentation 2: by Application

• General Surgery
• Gynecological Surgery
• Urological Surgery
• Bariatric Surgery
• Other Surgeries

The general surgery segment holds the maximum share in the Canada laparoscopy devices market, and the urological surgery segment is anticipated to be the fastest growing segment in the market during the forecast period 2022-2031.

Segmentation 3: by End User

• Hospitals
• Ambulatory Surgery Centers
• Others

Hospitals account for the major share of the Canada laparoscopy devices market. The growth in the hospital segment is primarily driven by the uptake of laparoscopic procedures by private hospitals.

Recent Developments in the Canada Laparoscopy Devices Market

• In June 2022, Ethicon, Inc., a subsidiary of Johnson & Johnson, launched the next-gen Echelon 3000 stapler, a closure device for surgical procedures.
• In April 2022, Ethicon, Inc., a subsidiary of Johnson & Johnson, launched Enseal X1 Straight Jaw Tissue Sealer, a closure device for stronger sealing in several surgical procedures.
• In December 2021, Medtronic plc received a Health Canada license for its Hugo RAS system for the expansion of robotic-assisted surgery.
• In December 2021, Intuitive Surgical Inc. received approval from the U.S. FDA for its 8 mm SureForm 30 curved-tip stapler (closure device).
• In July 2019, Intuitive Surgical, Inc. acquired the robotic endoscope business of Schölly Fiberoptic. Through this acquisition, the company gained access to Schölly’s robotic endoscope manufacturing line.

Demand – Drivers and Limitations

Following are the drivers for the Canada laparoscopy devices market:

• Rising Preference for Minimally Invasive Procedures
• Rising Regulatory Approvals for Robotic Systems
• Growing Geriatric Population
• Rising Bariatric Surgeries

The market is expected to face some limitations as well due to the following challenges:

• Long Waiting Time for Laparoscopic Procedures
• High Cost of Robotic-Assisted Surgery Systems

How can this report add value to an organization?

Type: The type segment helps the reader understand the different types of laparoscopy products available in the market. Moreover, the study provides the reader with a detailed understanding of products that fall under the two main segments, i.e., conventional laparoscopy devices and robotic assisted laparoscopy devices.

Growth/Marketing Strategy: The Canada laparoscopy devices market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, and regulatory and legal approvals. The favored strategy for the companies has been regulatory and legal activities and new offerings to strengthen their position in the market. For instance, in June 2022, Ethicon, Inc., a subsidiary of Johnson & Johnson, launched the next-gen Echelon 3000 stapler, a closure device for surgical procedures, and in December 2021, Medtronic plc received a Health Canada license for its Hugo RAS system for the expansion of robotic-assisted surgery.

Competitive Strategy: The key players in the Canada laparoscopy devices market analyzed and profiled in the study involve established and emerging players that offer different products for laparoscopic procedures. Moreover, a detailed competitive benchmarking of the players operating in the Canada laparoscopy devices market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, mergers, and acquisitions will help the reader understand the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some of the players in this market are:

• Applied Medical Resources Corporation
• Arthrex, Inc.
• B. Braun SE
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cook Group
• CONMED Corporation
• EIZO Corporation
• Intuitive Surgical, Inc.
• Johnson & Johnson
• KARL STORZ SE & Co. KG
• Medtronic plc
• Olympus Corporation
• Smith & Nephew plc
• Stryker Corporation
• Teleflex Incorporated

The post Canada Laparoscopy Devices Market: Focus on Product, Application, and End User – Analysis and Forecast, 2022-2031 first appeared on CRI Report.